$ARNA News S&P 500 back for another crack at major

New Post Public Reply Private Reply Replies (0) Message Board

Jan 13, 2015 at 12:20 PM

$ARNA News

S&P 500 back for another crack at major support 11:21 a.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy

Arena starts PAH study ralinepag 4:40 p.m. Jan. 12, 2015 - Seeking Alpha
Arena starts ralinepag PAH study 4:40 p.m. Jan. 12, 2015 - Seeking Alpha
Expect Arena's Belviq To Increase U.S. Market Share During 2015 Weight Loss Season 3:04 p.m. Jan. 12, 2015 - Seeking Alpha
A Deeper Look At Arena's Belviq Pricing 3:02 p.m. Jan. 12, 2015 - Seeking Alpha
Arena Pharmaceuticals (ARNA) Is Today's Strong On High Volume Stock 10:02 a.m. Jan. 12, 2015 - TheStreet.com
Orexigen's Contrave May Have Pricing Competition 9:13 a.m. Jan. 12, 2015 - Seeking Alpha
Arena Pharmaceuticals (ARNA) in Focus: Stock Falls 5.7% - Tale of the Tape 8:38 a.m. Jan. 12, 2015 - Zacks.com
Seeking Alpha's Biotech Weekly: Gilead Rises With Phenex, Bass's Patent Attack, And More 4:00 p.m. Jan. 9, 2015 - Seeking Alpha
Sales Of Arena's Belviq Close Out 2014 - What Will 2015 Bring? 2:49 p.m. Jan. 9, 2015 - Seeking Alpha
Arena Investors Should Watch New Pricing Of Belviq Closely 12:20 p.m. Jan. 9, 2015 - Seeking Alpha
Arena's APD334 Has Real Blockbuster Potential 11:23 a.m. Jan. 9, 2015 - Seeking Alpha
Arena Pharmaceuticals Soars on Positive Study Results - Analyst Blog 5:20 p.m. Jan. 8, 2015 - Zacks.com
Today's Perilous Reversal Stock: Arena Pharmaceuticals (ARNA) 9:46 a.m. Jan. 8, 2015 - TheStreet.com
Mid-Day Market Update: J C Penney Jumps On Strong Holiday Sales; Micron Shares Decline 12:11 p.m. Jan. 7, 2015 - benzinga.com
Arena Spikes On Pipeline News 11:02 a.m. Jan. 7, 2015 - Seeking Alpha
Arena autoimmune disease candidate successful in Phase 1b 10:41 a.m. Jan. 7, 2015 - Seeking Alpha
Why JCPenney, Dick’s and Arena Pharmaceuticals Are 3 of Today’s Best Stocks 10:34 a.m. Jan. 7, 2015 - InvestorPlace.com
Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops Estimates 9:59 a.m. Jan. 7, 2015 - benzinga.com
Arena Pharmaceuticals (ARNA) Showing Signs Of A Dead Cat Bounce Today 9:45 a.m. Jan. 7, 2015 - TheStreet.com
ARNA Stock Pops, And There’s Plenty More Where That Came From 9:11 a.m. Jan. 7, 2015 - InvestorPlace.com

Reveal Insider Trading for Yahoo, PulteGroup, Arena Pharmaceuticals, SolarCity, Alcoa, and Agenus 8:45 a.m. Today - PR Newswire - PRF
Arena Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Ralinepag for Pulmonary Arterial Hypertension 8:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
Reveal Earnings Forecast for Arena Pharmaceuticals, Petrobras, Alibaba, Apple, Gilead Sciences, and Applied Materials 8:45 a.m. Jan. 9, 2015 - PR Newswire - PRF
Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ® (lorcaserin HCl) CIV 8:00 a.m. Jan. 9, 2015 - PR Newswire - PRF
Critical Alerts For JC Penney, Arena Pharmaceuticals, Dick's Sporting Goods, International Business Machines and Cisco Systems Released By InvestorsObserver 9:31 a.m. Jan. 8, 2015 - PR Newswire - PRF
Insider Trading Research for Apple, Twitter, Las Vegas Sands, Google, Arena Pharmaceuticals, and J C Penney 8:45 a.m. Jan. 8, 2015 - PR Newswire - PRF
Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases 8:00 a.m. Jan. 7, 2015 - PR Newswire - PRF
Arena Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Jan. 6, 2015 - PR Newswire - PRF
Technical Coverage on Biotech Stocks - Arena Pharma, XOMA, Dyax, Mast Therapeutics, and Tekmira Pharma 8:50 a.m. Jan. 2, 2015 - PR Newswire - PRF
Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Related Compounds 8:00 a.m. Nov. 25, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 8:00 a.m. Nov. 24, 2014 - PR Newswire - PRF
Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics 8:40 a.m. Nov. 19, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference 8:00 a.m. Nov. 13, 2014 - PR Newswire - PRF
Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases 8:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference 8:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results 6:45 a.m. Nov. 3, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Cessation 6:30 a.m. Nov. 3, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 8:37 a.m. Oct. 31, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 8:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Phentermine HCl 6:20 p.m. Oct. 28, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Succession Planning in Turmoil: Only 42% Ready

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

HTX's Strategic Moves in Pakistan: A Crypto Frontier

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Machine Grabs Prime Dallas Property Amid Apartment Boom

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

FutureVault's AI Agents: Transforming Financial Workflows

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

The Chemical Industry and EPA: A Broken System?

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Cracking the Code of America's Delivery Addiction

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Compass Unveiled: Power Revolution in Private Equity

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Anecdotes by Artists Brings Raw Scent Stories to Sephora

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Davos Healthcare Aims to Revolutionize Hospital Ratings

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Leapora's Taskeen: Redefining Task Accountability

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...